FOERFARANDE FOER FRAMSTAELLNING AV TERAPEUTISKT AKTIVA ARALKYLIMIDAZOLDERIVAT

Arylmethylazoles of the formula I I in which Aryl is (substituted) phenyl or naphthyl; Z is CH or N; R1 and Q are H or alkyl; R2 is H, alk(en)yl or alkynyl; R3 and R4 are H, alkyl or other hydrocarbons; or R3 and R4 together are a -(CH2)2-11 chain or a bridged -(CH2)4-5 chain, and their acid additio...

Full description

Saved in:
Bibliographic Details
Main Authors GERHARDS,HERMANN JOSEF, DITTMAR,WALTER, LEVEN,MARGRET, ALPERMANN,HANS-GEORG, RAETHER,WOLFGANG, KAMPE,KLAUS-DIETER, SACHSE,BURKHARD, USINGER,PATRICIA, SCHACHT,ULRICH, SIEGEL,HERBERT
Format Patent
LanguageFinnish
Swedish
Published 25.02.1993
Edition5
Subjects
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
Online AccessGet full text

Cover

More Information
Summary:Arylmethylazoles of the formula I I in which Aryl is (substituted) phenyl or naphthyl; Z is CH or N; R1 and Q are H or alkyl; R2 is H, alk(en)yl or alkynyl; R3 and R4 are H, alkyl or other hydrocarbons; or R3 and R4 together are a -(CH2)2-11 chain or a bridged -(CH2)4-5 chain, and their acid addition salts, stereoisomers and optically active enantiomers possess outstanding antimycotic and antidepressant activity. They are obtained, inter alia, from arylmethylazoles II II which are reacted with a strong base and then with a carbonyl compound III O=CR3R4; thereafter, the product is reacted with the protic acid or with an alkyl halide IV R2Hal. If desired, the products are converted to the acid addition salts, or the stereoisomers or optically active enantiomers are resolved.
Bibliography:Application Number: FI19860003795